R-CHOP Chemotherapy

2

Review clinical trials related to R-CHOP Chemotherapy. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Pirtobrutinib + R-CHOP for Untreated Non-GCB DLBCL

To evaluate the efficacy and safety of pirtobrutinib combined with R-CHOP in patients with newly diagnosed non-GCB diffuse large B-cell lymphoma (DLBCL)

Participants needed: 34
Trial details
Phase: Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: Changzhou No.2 People's HospitalUpdated: Aug 6, 2026Locations: 1
Eligibility criteria

Histopathologically confirmed non-GCB diffuse large B-cell lymphoma (DLBCL) (per... [+7]

Central nervous system involvement; [+13]

Status: Recruiting

Chidamide Plus R-CHOP in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma With Other Molecular Subtypes

Evaluation of the Safety and Efficacy of CR-CHOP Treatment in Newly Diagnosed Double-Expressor DLBCL with Other Molecular Subtypes

Participants needed: 148
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: The First Affiliated Hospital with Nanjing Medical UniversityUpdated: Mar 24, 2025Locations: 1
Eligibility criteria

≥18 years of age; [+7]

Patients who meet any of the following criteria will be excluded from the study: [+8]